Share:
Share this content in WeChat
X
Clinical Article
Assessing glymphatic system dysfunction based on the DTI-ALPS method and choroid plexus remodeling in neuropsychiatric systemic lupus erythematosus: A correlation study
TANG Yanting  YANG Bingxia  ZHANG Ao  ZHAO Lianping  ZHOU Shuhong  ZHANG Wenwen 

DOI:10.12015/issn.1674-8034.2026.07.003.


[Abstract] Objective To investigate the characteristics of glymphatic system dysfunction and choroid plexus (ChP) morphological remodeling in patients with neuropsychiatric systemic lupus erythematosus (NPSLE) using diffusion tensor imaging analysis along the perivascular space (DTI-ALPS) and deep learning-based ChP segmentation, and to further explore their correlations with disease activity.Materials and Methods This prospective cross-sectional study included 47 patients with NPSLE and 59 concurrently recruited healthy controls between December 2023 and October 2025. All participants underwent conventional magnetic resonance imaging, high-resolution 3D T1-weighted imaging, and diffusion tensor imaging (DTI). The DTI-ALPS index was calculated to quantitatively evaluate glymphatic clearance. Furthermore, a 3D U-Net model was utilized to automatically segment the ChP of the lateral ventricles and quantify its volume. Partial correlation analyses, adjusting for age, years of education, and total intracranial volume, were performed to assess the associations between these neuroimaging metrics and the SLE Disease Activity Index (SLEDAI) score, Montreal Cognitive Assessment (MoCA) score, and disease duration.Results Compared to healthy controls, patients with NPSLE exhibited significantly reduced left DTI-ALPS indices (F = 6.235, P = 0.014), right DTI-ALPS indices (F = 10.168, P = 0.002) and global mean DTI-ALPS indices (F = 9.764, P = 0.002), and concomitantly increased left normalized ChP volume ratio (F = 9.532, P = 0.003), right normalized ChP volume ratio (F = 9.153, P = 0.003), and total normalized ChP volume ratio (F = 11.208, P = 0.001). Correlation analysis showed that, in the NPSLE group, the mean DTI-ALPS index was negatively correlated with the SLEDAI score (r = -0.436, P = 0.003), whereas there were no significant correlations between the mean DTI-ALPS index and the normalized ChP volume ratio, nor between these two parameters and disease duration or MoCA score (all P > 0.05).Conclusions NPSLE patients exhibit glymphatic dysfunction and ChP morphological remodeling, and DTI-ALPS, which is closely correlated with SLEDAI, may serve as an imaging biomarker for monitoring central nervous system involvement and assessing disease fluctuation.
[Keywords] systemic lupus erythematosus;neuropsychiatric systemic lupus erythematosus;diffusion tensor imaging;magnetic resonance imaging;choroid plexus;glymphatic system;neuroimmunity;disease activity

TANG Yanting1   YANG Bingxia1   ZHANG Ao1   ZHAO Lianping2   ZHOU Shuhong3   ZHANG Wenwen2*  

1 The First Clinical Medical College of Gansu University of Chinese Medicine, Lanzhou 730000, China

2 Department of Radiology, Gansu provincial Hospital, Lanzhou 730000, China

3 Department of Rheumatology and Immunology, Gansu Provincial Hospital, Lanzhou 730000, China

Corresponding author: ZHANG W W, E-mail: awen1007@126.com

Conflicts of interest   None.

Received  2026-03-25
Accepted  2026-06-09
DOI: 10.12015/issn.1674-8034.2026.07.003
DOI:10.12015/issn.1674-8034.2026.07.003.

[1]
HOI A, IGEL T, MOK C C, et al. Systemic lupus erythematosus[J]. Lancet, 2024, 403(10441): 2326-2338. DOI: 10.1016/S0140-6736(24)00398-2.
[2]
RICE-CANETTO T E, JOSHI S J, KYAN K A, et al. Neuropsychiatric systemic lupus erythematosus: a systematic review[J/OL]. Cureus, 2024, 16(6): e61678[2026-01-10]. https://doi.org/10.7759/cureus.61678. DOI: 10.7759/cureus.61678.
[3]
WEISSMAN-TSUKAMOTO R, CARROLL K R, DIAMOND B. Diffuse neuropsychiatric lupus: clinical evidence, immune-mediated mechanisms, and therapeutic insights[J/OL]. Semin Immunol, 2025, 79: 101981 [2026-01-10]. https://doi.org/10.1016/j.smim.2025.101981. DOI: 10.1016/j.smim.2025.101981.
[4]
VANARSA K, SASIDHARAN P, DURAN V, et al. Aptamer-based screen of neuropsychiatric lupus cerebrospinal fluid reveals potential biomarkers that overlap with the choroid plexus transcriptome[J]. Arthritis Rheumatol, 2022, 74(7): 1223-1234. DOI: 10.1002/art.42080.
[5]
LEGGE A C, HANLY J G. Recent advances in the diagnosis and management of neuropsychiatric lupus[J]. Nat Rev Rheumatol, 2024, 20(11): 712-728. DOI: 10.1038/s41584-024-01163-z.
[6]
GUAN X, HE X, LIU L. Neutrophil extracellular traps and neuropsychiatric lupus: signaling pathways involved in NET formation and mechanisms affecting the central nervous system[J/OL]. Autoimmun Rev, 2025, 24(11): 103897 [2026-01-10]. https://doi.org/10.1016/j.autrev.2025.103897. DOI: 10.1016/j.autrev.2025.103897.
[7]
BITANIHIRWE B K Y, LIZANO P, WOO T W. Deconstructing the functional neuroanatomy of the choroid plexus: an ontogenetic perspective for studying neurodevelopmental and neuropsychiatric disorders[J]. Mol Psychiatry, 2022, 27(9): 3573-3582. DOI: 10.1038/s41380-022-01623-6.
[8]
XU H, HEHNLY C, LEHTINEN M K. The choroid plexus: a command center for brain-body communication during inflammation[J/OL]. Curr Opin Immunol, 2025, 93: 102540 [2026-01-10]. https://doi.org/10.1016/j.coi.2025.102540. DOI: 10.1016/j.coi.2025.102540.
[9]
REYNOLDS J A, TORZ L, CUMMINS L, et al. Blood-CSF barrier clearance of ABC transporter substrates is suppressed by interleukin-6 in lupus choroid plexus spheroids[J/OL]. Fluids Barriers CNS, 2025, 22(1): 15 [2026-01-10]. https://doi.org/10.1186/s12987-025-00628-x. DOI: 10.1186/s12987-025-00628-x.
[10]
GUEYE M, PREZIOSA P, RAMIREZ G A, et al. Choroid plexus and perivascular space enlargement in neuropsychiatric systemic lupus erythematosus[J]. Mol Psychiatry, 2024, 29(2): 359-368. DOI: 10.1038/s41380-023-02332-4.
[11]
TAOKA T, MASUTANI Y, KAWAI H, et al. Evaluation of glymphatic system activity with the diffusion MR technique: diffusion tensor image analysis along the perivascular space (DTI-ALPS) in Alzheimer's disease cases[J]. Jpn J Radiol, 2017, 35(4): 172-178. DOI: 10.1007/s11604-017-0617-z.
[12]
MO J, HAN K, DENG K, et al. Glymphatic abnormality in systemic lupus erythematosus detected by diffusion tensor image analysis along the perivascular space[J]. Rheumatology (Oxford), 2025, 64(3): 1210-1219. DOI: 10.1093/rheumatology/keae251.
[13]
PETERSON A, SATHE A, ZARAS D, et al. Sex and APOE ε4 allele differences in longitudinal white matter microstructure in multiple cohorts of aging and Alzheimer's disease[J/OL]. Alzheimer's & Dementia, 2025, 21(1): e14343[2026-01-10]. https://doi.org/10.1002/alz.14343. DOI: 10.1002/alz.14343.
[14]
NASREDDINE Z S, PHILLIPS N A, BÉDIRIAN V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment[J]. J Am Geriatr Soc, 2005, 53(4): 695-699. DOI: 10.1111/j.1532-5415.2005.53221.x.
[15]
GONG W, ZHAI Q, WANG Y, et al. Glymphatic function and choroid plexus volume is associated with systemic inflammation and oxidative stress in major depressive disorder[J]. Brain Behav Immun, 2025, 128: 266-275. DOI: 10.1016/j.bbi.2025.04.008.
[16]
EISMA J J, MCKNIGHT C D, HETT K, et al. Deep learning segmentation of the choroid plexus from structural magnetic resonance imaging (MRI): validation and normative ranges across the adult lifespan[J/OL]. Fluids Barriers CNS, 2024, 21(1): 21 [2026-01-15]. https://doi.org/10.1186/s12987-024-00525-9. DOI: 10.1186/s12987-024-00525-9.
[17]
SCARPETTA V, BODALEO F, SALIO C, et al. Morphological and mitochondrial changes in murine choroid plexus epithelial cells during healthy aging[J/OL]. Fluids Barriers CNS, 2023, 20(1): 19 [2026-01-15]. https://doi.org/10.1186/s12987-023-00420-9. DOI: 10.1186/s12987-023-00420-9.
[18]
CHEN Y, ZHOU Y, BAI Y, et al. Macrophage-derived CTSS drives the age-dependent disruption of the blood-CSF barrier[J/OL]. Neuron, 2025, 113(7): 1082-1097.e8 [2026-01-15]. https://doi.org/10.1016/j.neuron.2025.01.023. DOI: 10.1016/j.neuron.2025.01.023.
[19]
LAAKER C, BAENEN C, KOVÁCS K G, et al. Immune cells as messengers from the CNS to the periphery: the role of the meningeal lymphatic system in immune cell migration from the CNS[J/OL]. Front Immunol, 2023, 14: 1233908 [2026-01-15]. https://doi.org/10.3389/fimmu.2023.1233908. DOI: 10.3389/fimmu.2023.1233908.
[20]
CORLATESCU A D, COSTIN H P, GONZÁLEZ-ESCAMILLA G, et al. Imaging the hidden player: choroid plexus enlargement in multiple sclerosis[J/OL]. Autoimmun Rev, 2026, 25(3): 104001 [2026-01-15]. https://doi.org/10.1016/j.autrev.2026.104001. DOI: 10.1016/j.autrev.2026.104001.
[21]
YAN Z J, YE M, LI J, et al. Early transcriptional and cellular abnormalities in choroid plexus of a mouse model of Alzheimer's disease[J/OL]. Mol Neurodegener, 2025, 20(1): 62 [2026-01-15]. https://doi.org/10.1186/s13024-025-00853-w. DOI: 10.1186/s13024-025-00853-w.
[22]
DAI T, LOU J, KONG D, et al. Choroid plexus enlargement in amyotrophic lateral sclerosis patients and its correlation with clinical disability and blood-CSF barrier permeability[J/OL]. Fluids Barriers CNS, 2024, 21(1): 36 [2026-01-15]. https://doi.org/10.1186/s12987-024-00536-6. DOI: 10.1186/s12987-024-00536-6.
[23]
RICHTER P, REZUS C, BURLUI A M, et al. Serum interleukin-6 in systemic lupus erythematosus: insights into immune dysregulation, disease activity, and clinical manifestations[J/OL]. Cells, 2025, 14(19): 1568 [2026-01-20]. https://doi.org/10.3390/cells14191568. DOI: 10.3390/cells14191568.
[24]
WANG K, HOU X, LU H, et al. Ectopic CD4+ T cells in choroid plexus mediate neuropsychiatric lupus symptoms in mice via interferon-γ induced microglia activation[J/OL]. J Autoimmun, 2024, 145: 103199 [2026-01-20]. https://doi.org/10.1016/j.jaut.2024.103199. DOI: 10.1016/j.jaut.2024.103199.
[25]
WU C H, LIAO W H, CHU Y C, et al. Very low-intensity ultrasound facilitates glymphatic influx and clearance via modulation of the TRPV4-AQP4 pathway[J/OL]. Adv Sci (Weinh), 2024, 11(47): e2401039 [2026-01-20]. https://doi.org/10.1002/advs.202401039. DOI: 10.1002/advs.202401039.
[26]
SCHIRGE P M, PERNECZKY R, TAOKA T, et al. Perivascular space and white matter hyperintensities in Alzheimer's disease: associations with disease progression and cognitive function[J/OL]. Alzheimers Res Ther, 2025, 17(1): 62 [2026-01-20]. https://doi.org/10.1186/s13195-025-01707-9. DOI: 10.1186/s13195-025-01707-9.
[27]
LV Y, DING X S, GAO L, et al. Glymphatic dysfunction in Parkinson's disease: aging-associated impairments, imaging biomarkers, and therapeutic strategies[J/OL]. Ageing Res Rev, 2026, 114: 102995 [2026-01-20]. https://doi.org/10.1016/j.arr.2025.102995. DOI: 10.1016/j.arr.2025.102995.
[28]
MUKHERJEE U, CHOWDHURY S, NAGADA K K, et al. Glymphatic system and intracerebral hemorrhage: identifying molecular targets for future therapeutic advancements[J/OL]. Ageing Res Rev, 2025, 112: 102900 [2026-01-20]. https://doi.org/10.1016/j.arr.2025.102900. DOI: 10.1016/j.arr.2025.102900.
[29]
OUYANG Q, YANG Y, WANG J, et al. C-Src/β-DG-mediated impairment of glia-vascular unit integrity via AQP4 depolarization contributes to secondary hydrocephalus after intraventricular hemorrhage[J]. Int J Surg, 2026, 112(2): 3028-3041. DOI: 10.1097/JS9.0000000000003867.
[30]
KANG S H, KIM S, KIM Y J, et al. Glymphatic dysfunction links vascular pathology to Alzheimer's biomarkers and cognitive decline[J/OL]. Alzheimers Res Ther, 2026 [2026-01-25]. https://doi.org/10.1186/s13195-026-01964-2. DOI: 10.1186/s13195-026-01964-2.
[31]
LIU H, LI H, TIAN B, et al. Alterations in the DTI-ALPS index and choroid plexus volume as brain-immune interfacing indicators in neuropsychiatric lupus erythematosus with inflammatory phenotype[J/OL]. Lupus Sci Med, 2026, 13(1): e001815 [2026-01-25]. https://doi.org/10.1136/lupus-2025-001815. DOI: 10.1136/lupus-2025-001815.
[32]
ZHAO R, SUN B, WEI P, et al. Potentiating cerebral perfusion normalizes glymphatic dynamics in systemic inflammation[J/OL]. Adv Sci (Weinh), 2025, 12(47): e03576 [2026-01-25]. https://doi.org/10.1002/advs.202503576. DOI: 10.1002/advs.202503576.
[33]
CARROLL K R, MIZRACHI M, SIMMONS S, et al. Lupus autoantibodies initiate neuroinflammation sustained by continuous HMGB1:RAGE signaling and reversed by increased LAIR-1 expression[J]. Nat Immunol, 2024, 25(4): 671-681. https://doi.org/10.1038/s41590-024-01772-6. DOI: 10.1038/s41590-024-01772-6.
[34]
ZHANG X, WANG W, BAI X, et al. Increased glymphatic system activity in migraine chronification by diffusion tensor image analysis along the perivascular space[J/OL]. J Headache Pain, 2023, 24(1): 147 [2026-01-25]. https://doi.org/10.1186/s10194-023-01673-3. DOI: 10.1186/s10194-023-01673-3.
[35]
HONG H, CHEN Y, TOZER D J, et al. MRI markers of cerebrospinal fluid dynamics predict dementia and mediate the impact of cardiovascular risk[J/OL]. Alzheimers Dement, 2025, 21(10): e70699 [2026-01-25]. https://doi.org/10.1002/alz.70699. DOI: 10.1002/alz.70699.
[36]
SIM T M, MAK A, TAY S H. Insights into the role of neutrophils in neuropsychiatric systemic lupus erythematosus: current understanding and future directions[J/OL]. Front Immunol, 2022, 13: 957303 [2026-01-25]. https://doi.org/10.3389/fimmu.2022.957303. DOI: 10.3389/fimmu.2022.957303.
[37]
GUI Y, BAI W, XU J, et al. Sex differences in systemic lupus erythematosus (SLE): an inception cohort of the Chinese SLE Treatment and Research Group (CSTAR) registry XVII[J]. Chin Med J (Engl), 2022, 135(18): 2191-2199. DOI: 10.1097/CM9.0000000000002360.
[38]
BASAIA S, SARASSO E, GARDONI A, et al. Unveiling hidden neurodegeneration in isolated REM sleep behavior disorder through MRI microstructure and glymphatic flow[J/OL]. NPJ Parkinsons Dis, 2025, 11(1): 346 [2026-02-05]. https://doi.org/10.1038/s41531-025-01193-8. DOI: 10.1038/s41531-025-01193-8.
[39]
TIRELI D, CHRISTENSEN J R, MUNCH T N, et al. Choroid plexus volume in brain disorders: a systematic review[J/OL]. Fluids and Barriers of the CNS, 2025, 22(1): 92 [2026-01-10]. https://doi.org/10.1186/s12987-025-00702-4. DOI: 10.1186/s12987-025-00702-4.

PREV Meta-analysis of gray matter volume and resting-state functional connectivity in type 2 diabetes-related cognitive impairment
NEXT Graph-theoretical comparison of brain network topology during motor imagery and motor execution
  



Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn